DrugPatentWatch Database Preview
Purdue Pharma Company Profile
What is the competitive landscape for PURDUE PHARMA, and what generic alternatives to PURDUE PHARMA drugs are available?
PURDUE PHARMA has nine approved drugs.
There are seventy-six US patents protecting PURDUE PHARMA drugs.
There are nine hundred and four patent family members on PURDUE PHARMA drugs in fifty-three countries and eleven supplementary protection certificates in five countries.
Summary for Purdue Pharma
| International Patents: | 904 |
| US Patents: | 76 |
| Tradenames: | 9 |
| Ingredients: | 9 |
| NDAs: | 9 |
| Patent Litigation for Purdue Pharma: | See patent lawsuits for Purdue Pharma |
| PTAB Cases with Purdue Pharma as petitioner: | See PTAB cases with Purdue Pharma as petitioner |
| PTAB Cases with Purdue Pharma as patent owner: | See PTAB cases with Purdue Pharma as patent owner |
Drugs and US Patents for Purdue Pharma
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Purdue Pharma Lp | HYSINGLA | hydrocodone bitartrate | TABLET, EXTENDED RELEASE;ORAL | 206627-007 | Nov 20, 2014 | RX | Yes | No | 8,309,060 | ➤ Try a Free Trial | Y | ➤ Try a Free Trial | |||
| Purdue Pharma Lp | OXYCONTIN | oxycodone hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 022272-006 | Apr 5, 2010 | RX | Yes | No | 8,894,988 | ➤ Try a Free Trial | Y | ➤ Try a Free Trial | |||
| Purdue Pharma Lp | OXYCONTIN | oxycodone hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 022272-003 | Apr 5, 2010 | RX | Yes | No | 8,309,060 | ➤ Try a Free Trial | Y | ➤ Try a Free Trial | |||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
Expired US Patents for Purdue Pharma
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Purdue Pharma Lp | BUTRANS | buprenorphine | FILM, EXTENDED RELEASE;TRANSDERMAL | 021306-001 | Jun 30, 2010 | 5,240,711 | ➤ Try a Free Trial |
| Purdue Pharma Lp | HYSINGLA | hydrocodone bitartrate | TABLET, EXTENDED RELEASE;ORAL | 206627-004 | Nov 20, 2014 | 6,488,963 | ➤ Try a Free Trial |
| Purdue Pharma Lp | MS CONTIN | morphine sulfate | TABLET, EXTENDED RELEASE;ORAL | 019516-001 | May 29, 1987 | 4,366,310 | ➤ Try a Free Trial |
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
Paragraph IV (Patent) Challenges for PURDUE PHARMA drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | Sublingual Tablets | 1.75 mg and 3.5 mg | ➤ Subscribe | 2012-04-10 |
| ➤ Subscribe | Transdermal System | 15 mcg/hr | ➤ Subscribe | 2013-12-16 |
| ➤ Subscribe | Extended-release Tablets | 30 mg and 60 mg | ➤ Subscribe | 2007-01-03 |
| ➤ Subscribe | Extended-release Tablets | 100 mg, 200 mg and 300 mg | ➤ Subscribe | 2009-06-18 |
| ➤ Subscribe | Transdermal System | 5 mcg/hr, 10 mcg/hr, and 20 mcg/hr | ➤ Subscribe | 2013-06-06 |
| ➤ Subscribe | Extended-release Tablets | 15 mg | ➤ Subscribe | 2007-02-15 |
International Patents for Purdue Pharma Drugs
| Country | Document Number | Estimated Expiration |
|---|---|---|
| Japan | 2009102405 | ➤ Try a Free Trial |
| Singapore | 170735 | ➤ Try a Free Trial |
| African Regional IP Organization (ARIPO) | 2397 | ➤ Try a Free Trial |
| Country | Document Number | Estimated Expiration |
Supplementary Protection Certificates for Purdue Pharma Drugs
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|
| 00714 | Netherlands | ➤ Try a Free Trial | PRODUCT NAME: ZOLPIDEM EN FARMACEUTISCH AANVAARDBARE ZOUTEN DAARVAN; NAT. REGISTRATION NO/DATE: RVG 108438 - 439 20130624; FIRST REGISTRATION: BE424286BE424295 2012180718 |
| 292 | Luxembourg | ➤ Try a Free Trial | PRODUCT NAME: COMBINAISON D OXYCODONE EN TANT QUE COMPOSANT A ET DE NALOXONE EN TANT QUE COMPOSANT B SOUS TOUTES LES FORMES PROTEGES PAR LE BREVET DE BASE |
| 636 | Luxembourg | ➤ Try a Free Trial | PRODUCT NAME: ZOLPIDEM ET SES SELS PHARMACEUTIQUEMENT ACCEPTABLES |
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
